Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21388312.
- Also identified by DOI 10.1056/NEJMct0807960.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 64-year-old woman receives the diagnosis of metastatic non-small-cell lung cancer (NSCLC), which has progressed during treatment with carboplatin, paclitaxel, and bevacizumab. Erlotinib therapy is recommended.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Protein Kinase Inhibitors
- Quinazolines